Warnex successfully passes FDA inspection of its bioanalytical facilities
25 Apr 2007 -
Warnex Inc. reported the favourable outcome from an inspection of its facilities performed by the U.S. Food and Drug Administration (FDA) and completed on April 6, 2007. The FDA inspected and reviewed Warnex's bioanalytical laboratories and their quality control systems, as well as several client-specific studies, during the recent audit. Warnex is compliant with FDA regulations and there were no
major observations requiring any corrective action.